top of page

Item List

The Future of Healthtech 2022

The Future of Healthtech 2022
Market reset from 2021's blockbuster levels marked by flight to quality and early-stage investment
I think this is one of the best times to be starting a company and one of the best times to be building responsibly."
Hemant Taneja, Managing Partner General Catalyst
In just the past nine months, the healthtech industry has seen dramatic shifts. Venture capital investment and deal pace are slowing from their peak in 2021, with valuations lowering and check sizes decreasing.

Rising interest rates, inflation and global geopolitical factors all created record market volatility. Public healthtech companies saw their shares drop at record paces.

Recent Posts

Portfolio Company


Clario and Strados Labs partner to bring new pulmonary endpoints to respiratory ...

Strados Labs

Wavemaker 360 News


Wavemaker Three-Sixty Health Announces 2023 Council of Strategic Advisors to Sup ...


Wavemaker 360 News


MedTech Color investing in Black, brown leaders in medical technology world ...

Fox 11 News

surf break copy_edited_edited.jpg
bottom of page